Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Atypical Hemolytic Uremic Syndrome after SARS-CoV-2 Infection: Report of Two Cases. | Int J Environ Res Public Health | 2022 | 36141710 | PubTator, text mining | PubMed |
| A Study of Peripheral Blood Parameters to Predict Response to Induction Chemotherapy and Overall Survival in Advanced Laryngeal Squamous Cell Carcinoma. | Curr Oncol | 2022 | 36135078 | PubTator, text mining | PubMed |
| Deciphering the endometrial immune landscape of RIF during the window of implantation from cellular senescence by integrated bioinformatics analysis and machine learning. | Front Immunol | 2022 | 36131919 | PubTator, text mining | PubMed |
| Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma. | Cell Discov | 2022 | 36127333 | PubTator, text mining | PubMed |
| Progressive enhancement of kinetic proofreading in T cell antigen discrimination from receptor activation to DAG generation. | Elife | 2022 | 36125261 | PubTator, text mining | PubMed |
| SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics. | Medicine (Baltimore) | 2022 | 36123895 | PubTator, text mining | PubMed |
| Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus. | Front Immunol | 2022 | 36119056 | PubTator, text mining | PubMed |
| Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. | Front Immunol | 2022 | 36119022 | PubTator, text mining | PubMed |
Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis. | Front Genet | 2022 | 36118856 | PubTator, text mining | PubMed |
| Peroxidase is a novel potential marker in glioblastoma through bioinformatics method and experimental validation. | Front Genet | 2022 | 36118855 | PubTator, text mining | PubMed |
| Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence. | BMC Genomics | 2022 | 36114454 | PubTator, text mining | PubMed |
| Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs. | Front Genet | 2022 | 36110218 | PubTator, text mining | PubMed |
| Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm. | Nat Commun | 2022 | 36100613 | PubTator, text mining | PubMed |
| Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma. | Nat Med | 2022 | 36097221 | PubTator, text mining | PubMed |
| Automated, scaled, transposon-based production of CAR T cells. | J Immunother Cancer | 2022 | 36096530 | PubTator, text mining | PubMed |
| Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma. | Front Genet | 2022 | 36092903 | PubTator, text mining | PubMed |
| Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer. | Front Genet | 2022 | 36092873 | PubTator, text mining | PubMed |
Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response. | Front Mol Biosci | 2022 | 36090045 | PubTator, text mining | PubMed |
| An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer. | Front Genet | 2022 | 36081989 | PubTator, text mining | PubMed |
| Sex Differences in Coronary Artery Disease and Diabetes Revealed by scRNA-Seq and CITE-Seq of Human CD4+ T Cells. | Int J Mol Sci | 2022 | 36077273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=39